Independent Chair appointed to lead QEII Health and Biomedical Precinct

Western Australia’s Health and Biomedical Precinct at Queen Elizabeth II Medical Centre (QEII) today reached a significant milestone with the appointment of Ms Paula Rogers as the inaugural Independent Chair of the Precinct Leadership Group (PLG).

Supported by a $1.9 million investment from the WA Government, the PLG is tasked with guiding the development of the Precinct’s long-term vision and governance structure. The aim is for the Precinct to become an independently governed, self-sustaining entity by 2027, enhancing collaboration between universities, health service providers, and industry.

The QEII Precinct is set to become one of the largest health and biomedical hubs in the southern hemisphere, driving improvements in research translation and innovation across WA.

Ms Rogers brings extensive experience in stakeholder engagement and strategic leadership, having previously served as CEO of the Committee for Perth and WA State Director at the Committee for Economic Development of Australia (CEDA). Her board experience includes North Metropolitan Health Service and Edith Cowan College, and she currently serves on the Black Swan Philanthropy Advisory Council, Rugby WA and Edith Cowan University School of Business and Law Advisory Council.

The establishment of the Precinct Leadership Group complements ongoing investments in WA’s health and medical innovation ecosystem, including:

The Murray Street Launchpad, supporting early-stage innovation projects, with construction expected to finish mid-next year.

The Floreat Biomedical Manufacturing Hub, enabling biomedical product manufacturing and commercial launches, backed by a $50 million commitment.

The appointment of an Independent Chair is designed to ensure expert facilitation and governance during this critical establishment phase, supporting Western Australia’s ambition to become a national leader in biomedical research and innovation.